Physician profile
Sarah Harmon
NPI 1881304525
$1,209.00
in general payments reported to CMS, 2019-2025
14 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $592 · 2024: $322 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,010.01 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $422.53 | 2023-2024 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $204.21 | 2023-2024 | Arexvy, Trelegy Ellipta, Nucala |
| Sobi, INC | $99.99 | 2025 | |
| Daiichi Sankyo INC. | $99.00 | 2025 | Enhertu |
| Novocure INC. | $95.85 | 2025 | Optune Gio |
| Amgen INC. | $84.75 | 2023-2024 | Tezspire |
| Philips North America LLC | $41.29 | 2023-2024 | (Ak6) Vest Therapy |
| Genzyme Corporation | $36.07 | 2024 | |
| Baxter Healthcare | $30.42 | 2023 | Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| United Therapeutics Corporation | $28.74 | 2024 | Tyvaso |
| Jazz Pharmaceuticals INC. | $17.68 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.70 | 2023 | Ofev |
| Regeneron Healthcare Solutions, INC. | $16.08 | 2024 | Dupixent |
| Azurity Pharmaceuticals, INC. | $15.69 | 2023 | Horizant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Harmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.